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Abstract: 5-Methylpyrazole derivative 1 is metailated at the C-5 methyl carbon atom to form lithium 5- 
lithiomethyl-3-methylpyrazole-l-carboxylate 3 which on reaction with a-oxoketene dithioacetals 4a-d, 
12a..¢ and 15a-b yields ubstituted and annelated pyrazolo[1,5-a]pyridines 7a-d, 13a..e and 16a-b. 
© 1999 Elsevier Science Ltd. All rights reserved. 
Metallation studies on N-methyl or N-benzylpyrazoles have revealed that the N-alkyl group 
preferentially undergoes deprotonation to yield kineticaUy favoured carbanions which, at higher temperatures, 
exchange protons from the pyrazole ring to give the thermodynamically more stable 5-1ithiopyrazole anions in 
high yields [1,2]. Reactions of these anions with various electrophiles have been examined and their formation 
is fully established. Also, 1,5-dimethyl- and 1,3,5-trimethyl- pyrazoles have been shown to undergo exclusive 
N-methyl deprotonation i preference to any of the ring methyl protons [1,2,3]. Thus to our knowledge no 
studies are reported in the literature on deprotonation of pyrazole ring methyl groups through direct 
metallation. However, Katritzky and Akutagawa [4] have reported that 2-methylindole, when protected as its 
I-lithium earboxylate, readily underwent lithiation at the ct-methyl carbon to afford the corresponding lithium 
2-1ithiomethylindole-l-carboxylate in excellent yield. The anion reacted with various electrophiles to yield the 
corresponding 2-substituted methylindoles in high yields. This was the first example of the use of carbon 
dioxide for protection, activation and deprotonation sequence in a one-pot reaction. We have successfully 
reacted the same anion with various ct-oxoketene dithioacetals to yield the corresponding carbinol thioacetals 
which were cyclized in the presence of H3PO4 to afford the corresponding carbazoles in excellent yields [5]. 
We therefore decided to attempt the deprotonation of less activated ring methyl protons situated adjacent o 
the NH group of heterocycles. For example, we have selected 3,5-dimethylpyrazole as a typical example to 
generate its lithium 5-1ithiomethyl-3-methypyrazole-l-carboxylate 3 and study its reaction with various cc- 
oxoketene dithioacetals [6] to afford the corresponding heteroaromatic products in accordance with our 
heteroaromatie annelation protocol [7]. We have indeed generated the anion 3 in high yield and reacted with 
ct-oxoketene dithioacetals to afford pyrazolo[1,5-a]pyridines involving cyelization through ring nitrogen 
rather than ring carbon. We report hese results in this paper. 
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Results and Discussion 
In a typical experiment, pyrazole 1 reacted with n-BuLi in TI-IF to afford the corresponding fight 
yellow colored N-lithio-3,5-dim~hylpyrazole t  which carbon dioxide was bubbled at -78"C; during this time 
the light yellow colored solution turned into a colorless uspension of lithium pyrazole arboxylate 2. The 
excess of carbon dioxide and the solvent were removed under vacuum to afford the corresponding colorless 
lithium salt 2 which was deprotonated with t-BuLi in hexane/TI-IF at -78"C to yield light yellow colored 
dianion 3 (Scheme 1). 
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Scheme I 
The dianion 3 reacted with c~-oxoketenc dithioacetal 4a and the corresponding carbinolthioacetal 5a
was obtained in good yield. Treatment of 5a with H3PO4 at 120oc followed by work-up afforded a colorless 
solid which was characterized as7-methylthio-2,5,6-trimethylpyrazolo[1,5-a]pyridine 7a instead of indazole 9 
(R 1 = R 2 = Me) on the basis of spectral and analytical data. Thus the IR spectrum of 7a did not display any 
peak due to NH group between 3200-3400 cm "1. Also its ]H N-MR spectrum (300 MHz) did not show any 
D20-exchangable signal between 5 8-14 characteristic of indazole and pyrazole ring N-H [8]. The 
pyrazolo[1,5-a]pyridine structure 7a was further supported by the presence ofa singlet at 5 6.08 due to H-3 
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in line with the earlier reported values [9]. In its 13C NMR spectrum, 7a displayed acharacteristic C-3 signal 
at 8 95.54 confirming the structural assignment [10]. Dethiomethylation of 7a with Raney Ni afforded 
sulfur-free 8a in 94% yield. The IH NMR spectrum of 8a established that the anion 3 has followed 1,2- 
addition mode to 4a since the ring protons H-4 and H-7 in 8a were observed as singlets. The other possible 5- 
methylthiopyrazolopyridine isomer 10a would have yielded, after desulfurization, the corresponding 6,7- 
disubstituted pyrazolopyridine l l a  for which the resonances for H-4 and H-5 protons would have appeared as 
doublets through o-coupling. The presence of a low field singiet at 8 8.09 due to H-7 in the ~H NMR spectrum 
of 8a is also in agreement with the reported values for these compounds [9,11] while no proton of the aromatic 
ring of indazole appears at such a high 8 value [8]. The other open chain ketene dithioacetals 4b-d reacted 
similarly with 3 to afford the corresponding carbinol thioacetals 5b-d, which were cyclized as described above 
to afford the corresponding 2-methyi-7-methyithio-5-substituted pyrazolo[1,5-o]pyridines 7b-d in 72-82% 
overall yields. The probable mechanism for the formation ofpyrazolo[1,5-a]pyridines 7 from 5 is shown in the 
Scheme 2. Apparently the decarboxylated carbinolthioacetal 6 cyclizes at the electron rich ring nitrogen 
instead of at C-4 to give pyrazolo[1,5-a]pyridines 7 rather than the indazoles. The cyclic oxoketene 
dithioacetals 12a-¢ reacted similarly with 3 to afford the corresponding 5,6-cycloalkanopyrazolo[1,5-a]- 
pyridines 13a-c in 67-70% overall yields (Scheme 2). The structures of all these products were established 
with the help of spectral and analytical data. The methylthiopyrazolo[1,5-a]pyridines 7b-d and 13c were also 
subjected to Raney Ni desulfurization when the corresponding sulfur-free 8b-d and 14c were obtained in 85- 
92% overall yields. 
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The reaction of ct-oxoketene dithioacetals 15a and l$b derived from tetralone and 2,3,4,5-tetrahydro- 
benzo[b]thiepin-5-one with 3 under identical reaction conditions afforded novel tetracyclic pyrazolopyridines 
16a and 16b in 63% and 64% yields respectively (Scheme 4). 
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In conclusion, we have successfully prepared lithium 5-lithiomethyl-3-methyl-pyrazole-l-carboxylate 
3 and reacted it with various a-oxoketene dithioacetals to develop a new method for the synthesis of 
substituted and condensed pyrazolo[1,5-a]pyridines. Many pyrazolo[1,5-a]pyridines have been shown to be 
biologically important, exhibiting anti-inflammatory, antiaUergic, bronchodilating and adenosine antagonist 
activity [12]. Most of the reported methods [13] for the synthesis of pyrazolo[1,5-a]pyridines utilize N- 
aminopyridinium salt precursors involving their reaction with 1,3-dicarbonyl compounds [14], acylating 
agents [11,15], activated acetylenic ompounds [16], nitroolefins [17], dimethyl 1-chlorofumarate [18], 
alkoxymethylene carbonyl compounds [ 19] and activated acetonitrile derivatives [20]. Other syntheses involve 
reaction of 1-aminopyridine-2-thione with c¢-bromocarbonyl compounds [21], condensation f l-amino-2- 
pyridones with active methylene ketones [22], base treatment of 1-[2-(substitutedmethylthio)methyiene- 
amino]pyridinium halides [23], reaction of tfiazolopyridinium ylides with dimethyl acetylenedicarboxylate 
[24], reaction of 1-aminopyridin-2-imines with 1,3-dicarbonyl compounds [25] and thermal isomerization of 
allylidene dihydropyridine derivatives [26] or conjugated azines [27]. Most of these methods require 
substituted pyridine precursors for the synthesis of pyrazolo[1,5-a]pyridines. On the other hand, methods 
based on more easily accessible pyrazole derivatives are not described in the literature. One isolated example 
[28] involves thermolysis of Diels-Alder adduct of pyrazoline with tetraphenylcyclopentadienone to afford 
pentaphenylpyrazolo[ 1,5-a]pyfidines. The reaction of cyanomethylpyrazole with1,3-dicarbonyl compounds i
also reported [29] to yield pyrazolo[1,5-a]pyridines which were not properly characterized. The present 
method utilizing lithiomethylpyrazole dianion 3 is therefore unique and efficient for the synthesis of novel 
pyrazolo[1,5-a]pyridines with diverse structural flexibility and full control of the substitution pattern in the 
pyridine ring. 
Experimental Section 
Melting points were obtained on a Thomas Hoover capillary melting point apparatus and are 
uncorrected. IR spectra were recorded on a Perkin Elmer 983 spectrophotometer. IH NMR (300 MHz) and 
13C NMR (75 MHz) spectra were recorded on Bruker ACF-300 spectrometer. Chemical shifts are reported in 8 
(ppm) relative to tetramethylsilane. Mass spectra were obtained on a Jeol D-300 mass spectrometer. Elemental 
analyses were carded out on a Heraens CHN-O-Rapid analyzer. 
All reactions were conducted inoven-dried (120°C) glass ware under a dry argon/nitrogen atmosphere. 
All reactions were monitored by TLC on glass plates coated with silica gel (Aeme) containing 13% calcium 
sulfate as binder and visualization of compounds was accomplished by exposure to iodine vapour or by 
spraying with acidic potassium permanganate solution. Column chromatography was carded out using Acme 
silica gel (60-120 mesh). THF was distilled from sodium benzophenone ketyl prior to use. 3,5- 
Dimethylpyrazole was prepared according to the literature procedure [30]. n-BuLi and t-BuLi were purchased 
from Aldrich. The a-oxoketene dithioacetals were prepared according to the reported procedures [6]. 
General Procedure for the Preparation of Lithium 5-Llthiomethyl-3-methylpyrazole-l-carboxylate ud  
its Reaction with ~-Oxoketene Dlthloacetais: Synthesis of Substituted ud  Annelated Pyrazolo- 
[1,5-a]pyridines. 
To a stirred solution of 3,5-dimethylpyrazole 1 (15 retool) in THF (25 ml) at -78°(2, n-BuLi in hexane 
(16 mmol) was added when the reaction mixture turned fight yellow. After 30 rain, analytical grade carbon 
dioxide was bubbled for 5 min at -78°C during which time the light yellow colored solution turned into a 
colorless uspension of lithium pyrazole-2-carboxylate 2. The excess of carbon dioxide and the solvent were 
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removed under vacuum to afford the lithium salt 2 as colorless olid. Fresh THF (30 ml) was added to the 
reaction mixture, maintaining the temperature at -78°C, followed by dropwise addition of t-BuLi (16 mmol) 
in hexane when yellow colored dianion 3 was formed. After I 11, the appropriate a-oxoketene dithioacetal (I 5 
mmol) in THF (25 ml) was added ropwise whilst maintaining the temperature at-78C. The reaction mixture 
was further stirred for 1 hr at room temperature and then poured into saturated NI-I4CI solution (250 ml) and 
extracted with chloroform (3x60 ml). The combined organic extracts were washed with water, dried over 
sodium sulfate and the solvent distilled off to give the crude carbinolthioacetals which were used as such for 
further cyclization. 
To the crude carbinolthioacetals, orthophosphoric acid (20 ml) was added and heated with stirring at 
120°C for 2-3 h. It was then poured into ice cold water (250 ml), extracted with chloroform (3x50 ml), washed 
with water and dried over sodium sulfate. The solvent was distilled off and the crude products obtained were 
purified by column chromatography (silica gel) using hexane-ethyl acetate (97:3) as eluent. 
7-Methylthio-2,5,6-trimethylpyrazolo[1,5-a] pyridine 7a: 
Colorless crystals; Yield 78%; m.p. 75-76°C (ether); IR (KBr): 1479, 1529, 1626, 2916 cm'~; IH NMR (300 
MI-Iz, CDC13/CCI4): 82.22 (s, 3H, CH3), 2.44 (s, 3H, CH3), 2. 47 (s, 3H, CH3), 2.52 (s, 3H, CH3), 6.08 (s, 1H, 
H-3), 7.07 (s, 1H, H-4); 13C NMR (75 MHz, CDC13/CCI4): 8 14.06, 15.70, 16.71, 20.76, 95.54, 115.71, 
124.95, 131.79, 133.06, 139.74, 150.04; MS (m/z, %) 206 (M +, 88.9), 172 (100); Anal. Calcd. for CHH]4N2S 
(206.20): C, 64.02; H, 6.84; N, 13.59%. Found: C, 64.32; H, 6.63; N, 13.82%. 
2,5-Dimethyl-7-(methylthlo)pyrazolo[1,5-a]pyridine 7b: 
Colorless crystals; Yield 72%; m.p. 98-99°C (ether); IR (KBr): 1289, 1497, 1621, 2986 cm'l; IH NMR (300 
MI-Iz, CDC13/CCh): 8 2.24 (s, 3H, CH3), 2.47 (s, 6H, (CH3)2), 6.08 (s, 1H, H-3), 6.15 (brs, 1H, H-6), 6.88 Cots 
1H, H-4); t3C NMR (75 MHz, CDC13/CC14): ~ 13.87, 14.01, 21.17, 95.22, 108.12, 111.27, 133.23, 138.32, 
141.19, 151.29; MS (m/z, %); 192 (M +, 64.8), 159 (100): Anal. Calcd. for CI0H~2N2S ( 192.28): C, 62.46; H, 
6.29; N, 14.57%. Found: C, 62.92; H, 6.53; N, 14.78%. 
2-Methyl-S-phenyl-7-(methyl~lo)pyrazolo[1,5-a]pyrldine 7c: 
Colourless crystals; Yield 80%; m.p. 133-135°C (chloroform-hexane); IR (KBr): 1499, 1610, 2982 cm'l; IH 
NMR (300 MHz, CDCI3): 6 2.53 (s, 3H, CH3), 2.60 (s, 3H, CH3), 6.31 (s, 1H, H-3), 6.65 (s, 1H, H-4), 7.30- 
7.45 (m, 4H, ArH), 7.56-7.59 (m, 2H, ArH); t3C NMR (75 MHz, CDCI3): 5 14.19, 14.22, 97.07, 105.84, 
110.04, 126.88, 127.95, 128.88, 136.40, 139.25, 139.40, 141.38, 152.28; MS (m/z, %): 254 (M +, 93.7), 221 
(100). Anal. Calcd. for CtffIt4N2S (254.36): C, 70.83; H, 5.55; N, 11.01%. Found: C, 71.02; H, 5.48; N, 
11.12%. 
5-(4-Me~oxyphenyl)-2-methyl-7-(methylthlo)pyrazoio[1,5-a]pyridine 7d: 
Colorless crystals; Yield 82%; m.p. 152-153°C (chloroform-hexane); IR (KBr): 1471, 1497, 1524, 1603, 2982 
cm'l; IH NMR (300 MHz, CDC13): 8 2.53 (s, 3H, CH3), 2.63 ( s, 3H, SCH3), 3.84 ( s, 3H, OCH3), 6.31 (s, 1H, 
H-3), 6.64 Cors, 1H, H-6), 6.97 (d, J = 8.7 Hz, 2H, ArH), 7.34 (brs, 1H, H-4), 7.54 (d, J = 8.7 Hz, 2H, ArH); 
~3C NMR (75MHz, CDC13): 8 14.28, 15.27, 55.40, 95.39, 109.71, 110.67, 113.81, 125.67, 130.63, 134.98, 
139.29, 142.45, 151.79, 160.52; MS (m/z, %); 284 (M +, 81.8), 251 (100); Anal. Caled. for Cid'Ildq2OS 
(284.38): C, 67.58; H, 5.67; N, 9.85%. Found: C, 67.83; H, 5.81; N, 10.31%. 
2-Methyl-8-(methylthio)cyclopenta[d]pyrazolo[1,5-a]pyridint 13a: 
Colourless crystals; Yield 67%; m.p. 87-88°C (chloroform-hexane); IR (KBr): 1539, 1588, 1629, 1683, 2926 
cm'l; IH NMR (300 MI-Iz, CDC13/CCh): 5 2.09-2.16 (m, 2H, CH2), 2.49 (s, 3H, CH3), 2.61 (s, 3H, SCH3), 
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2.93 (t, 2H, CH2), 3.04 (t, 2H, CH2), 6.16 (s, 1H, H-3), 7.16 (s, 1H, H-4); MS (m/z, %): 218 (M +, 48.2), 185 
(100); Anal. Caled. for CI2H14N2S (218.26): C, 66.04; H, 6.47; N, 12.83%. Found: C, 65.89; H, 6.51; N, 
12.93%. 
2-Methyl-9-methylthio-5,6,7,8-tetrahydropyrazolo [1,5-b]lsoquinoline 13b: 
Colorless crystals; Yield 70%; m.p. 97-980C (ether); IR (KBr): 1425, 1529, 1622, 2932 cm'l; IH N'MR (300 
MHz, CDC13/CC14): 8 1.80-2.00 (m, 4H, (CH2)2) , 2.42 (s, 3H, CH3), 2.44 (s, 3H, CH3), 2.63 Cort, 2H, CH2), 
3.07 Cort, 2H, CH2), 6.02 (s, 1H, H-3), 6.86 (s, 1H, H-4); 13C N]V[R (75 MHz, CDCI3/CCLt): 8 13.93, 14.37, 
21.54, 22.34, 24.52, 24.87, 94.20, 106.70, 116.44, 134.95, 135.91, 139.56, 150.03; MS (re~z, %): 232 (M +, 
100), 217 (37.6); Anal. Calcd. for C13HI6N2S (232.35): C,67.20; H, 6.94; N, 12.06%. Found: C, 67.52; H, 
7.28; N, 12.41%. 
2-Methyl-11-(methylthlo)eyelooeta[d]pyrazolo[1,5-alpyridine 13e: 
Light yellow crystals; Yield 67%; m.p. 81-820C (chloroform-hexane); IR (KBr): 1473, 1682, 2921 cm'i; IH 
NMR (300 MI-Iz, CDCI3/CCI4): 8 1.20-1.34 Corm, 2H, CH2), 1.40-1.48 Corm, 2H, CH2), 1.65-1.75 Corm, 4H, 
(CH2)2), 2.48 (s, 3H, CH3), 2.57 (s, 3H, SCH3), 2.75 Cort, 2H, CH2), 3.09 Cort, 2H, CH2), 6.11 (s, 1H, H-3), 
7.11 (s, 1H, H-4); ~3C NMR (75 MHz, CDCIgCCI4): 8 14.08, 15.77, 25.36, 26.32, 28.06, 31.02, 32.72, 33.67, 
95.56, 115.27, 128.96, 131.59, 138.40, 140.08, 150.08; MS (m/z,%): 260 (M+,7.4). Anal. Calcd. for CIsH20N2S 
(260.40): C, 69.19, H, 7.74, N, 10.76%. Found: C, 69.32; H, 7.70; N, 10.83%. 
5,6-Dihydro-9-methyl-7-(methylthlo)benzo[/] pyrazolo[5,l-b] isoquinoline 16a: 
Light yellow crystals; Yield 63%; m.p. 107oc (chloroform-hexane); IR (KBr): 1445, 1496, 1614, 2921 cm'l; 
1H NMR (300 MI-Iz, CDCI3/CCL,): 8 2.47 (s, 3H, CH3), 2.50 (s, 3H, CH3), 2.86 (s, 4H, (CH2)2), 6.17 (s, 1H, 
10-H), 7.03 (s, 1H, ll-H), 7.24-7.40 (m, 3H, ArH), 9.29 (d, J = 8.1 Hz, 1H, ArH); 13C NMR (75 MHz, 
CDC13/CCI4): 8 14.14, 15.03, 24.06, 28.73, 94.68, 109.36, 119.93, 126.18, 126.97, 127.84, 128.46, 128.72, 
132.80, 134.78, 138.26, 141.71,150.37; MS (re~z, %): 280 (M +, 100); Anal. Caled. for CI7HI6N2S (280.39): C, 
72.82, H, 5.75, N, 9.99%. Found: C, 72.69, H, 5.81, N, 9.93%. 
6,7-Dihydro-3,10-dlmethyl-8-(methylthio)benzo [b]pyrazolo [l',5'-l,6]pyrido [4,3-d]thlepin 16b: 
Colourless crystals; Yield 64%; m.p. 190oc (chloroform-hexane); IR (KBr): 1467, 1524, 1621, 2917 cm'l; IH 
NMR (300 MI-Iz, CDC13/CC14): 8 2.38 (s, 3H, CH3), 2.51 Cots, 4H, CH3 + H), 2.64 (s, 3H, CH3), 2.91 Corm, 
1H), 3.46 Corm, 1H), 3.80 Corm, 1H), 6.28 (s, 1H, 1 l-H), 7.14 (s, 1H, ArH), 7.27 Cot's, 2H ArH), 7.38 Cors, 1H, 
ArH). ~3C NMR (75 MHz, CDCI3/CCL)): 8 14.07, 15.75, 20.76, 29.34, 37.42, 97.17, 115.42, 126.03, 128.42, 
129.30, 130.91,130.99, 135.51, 138.05, 138.11,139.93, 142.07, 150.44; MS: (re~z, %): 326 (M +, 100%). Anal. 
Calcd. for CIsH18N2S2 (326.49): C, 66.22; H, 5.56; N, 8.58%. Found: C, 66.36; H, 5.67; N, 8.51%. 
General Procedure for Dethiomethylation f 7a-d and 13e with Raney Nickel. 
To a solution of corresponding methylthiopyrazolo[1,5-a]pyridine (2 r tool) in ethanol (30 ml), Raney 
nickel (W2, 6 times by weight) was added and the suspension was re fluxed with stirring for 2-3 h (monitored 
by tic). The reaction mixture was then cooled, filtered through sintered funnel and the residue was washed 
with ethanol. Ethanol was removed under vacuum and the residue was dissolved in chloroform (100 ml).The 
chloroform solution was then washed with water, dried over anhydrous sodium sulfate and concentrated to
give crude products from which analytically pure compounds were obtained by passing through a small silica 
gel column using hexane as eluent. 
2,5,6-Trimethylpyrazolo [1 ,S-a] pyridine 8a: 
Colorless crystals; Yield 94%; m.p. 94-950C (chloroform-hexane); IR (KBr): 1529, 1626, 2916 cm'l; IH NMR 
(300 MI-Iz, CDCI3): 8 2.17 (s, 3H, CH3), 2.23 (s, 3H, CH3), 2.43 (s, 3H, CH3), 6.07 (s, 1H, H-3), 7.10 (s, 1H, 
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H-4), 8.09 (s, 1H, H-7); 13C N]VIR (75 MI-Iz, CDCI3)" 8 13.86, 16.68, 19.46, 94.33, 115.56, 120.67, 125.65, 
134.45, 140.32, 150.88; MS (m/z, %); 160 (M +, 100); Anal. Caled. for C|0HI2N 2(160.22): C, 74.97; H, 7.55; 
N, 17.48%. Found: C, 75.23; H, 7.79; N, 17.73%. 
2,5-Dimethylpyrazolo[1,5-a] pyridine 8b: 
Light yellow crystals; Yield 90%; m.p. 78-79°C (chloroform-hexane); IR (KBr): 1468, 1737, 2925 cm'l; IH 
NMR (300 MI-Iz, CDC13): 8 2.31 (s, 3H, CH3), 2.45 (s, 3H, CH3), 6.11 (s, 1H, H-3), 6.44 (dd, J=  1.8, 7.1 Hz, 
1H, H-6), 7.12 Cors, 1H, H-4), 8.22 (d, J = 7.1 I-Iz, 1H, H-7); 13C N'MR (75 MHz, C'DCI3): 8 13.9, 21.12, 
94.90, 113.32, 115.55, 127.29, 133.78, 141.37, 151.80; MS (m/z, %): 146 (M+,100). Anal. Calcd. for CgHIoN2 
(146.19): C, 73.94; H, 6.89; N, 19.16%. Found: C, 73.78; H, 6.92; N, 19.23% 
2-Methyl-5-phenylpyrazolo [1,5-a] pyridine 8e: 
Colorless crystals; Yield 85%; m.p. 120-121°C (chloroform-hexane); IR (KBr): 1522, 2919 cm'l; 1H N-MR 
(300 MHz, CDC13/CCI4): 82.46 (s, 3H, CH3), 6.21 (s, 1H, H-3), 6.86 (dd, J=  1.8, 7.2 Hz, 1H, H-6), 7.28-7.56 
(In, 6H, Arid), 8.37 (d, J = 7.1 Hz, 1H, H-7); ~3C NMR (75 MHz, CDCI3/CCI4): 8 13.77, 96.24, 110.06, 
113.78, 126.46, 127.63, 127.79, 128.61,135.85, 138,93, 140.85, 151.68; MS (re~z, %): 208 (M +, 100%), Anal. 
Calcd. for CI4HI2N2 (208:26): C, 80.74, H, 5.81; N, 13.45%. Found: C, 81.07, H, 5.85, N, 13.39%. 
5-(4-Methoxyphenyl)-2-methyi-pyrazolo [1,5-alpyridine 8d: 
Colorless crystals; Yield 92%; m.p. 144-145oC (chloroform-hexane); IR (KBr): 1487, 1514, 1639, 2901 cm-l; 
1H NMR (300 MHz, CDC13/CC14): 8 2.49 (s, 3H, CH3), 3.86 (s, 3H, OCH3), 6.26 (s, lH, H-3), 6.88 (dd, 1H, 
J = 2, 7.3 Hz, H-6), 6.97 (d, 2H, J=  8.8 Hz, ArH), 7.51 (in, 1H, H-4), 7.55 (d, 2H, J=  8.9 Hz, ArH), 8.36 (d, 
1H, J=  7.2 Hz, H-7); MS (re~z, %): 238 (M +, 100); 223 (82). Anal. Calcd. for CIsHI4N20 (238.29): C, 75.61; 
H, 5.92; N, 11.76%. Found: C, 75.96; H, 6.19; N, 12.03%. 
2-Methyleyelooeta[d]pyrazolo[1,5-alpyridine 14e: 
Colorless crystals, Yield 91%; m.p. 75-760C (chloroform-hexane); IR (I~r): 1441, 1528, 1602, 2952, cm'l; 
IH NMR (60 MHz, CDC13): 8 1.00-2.00 Corm, 8H), 2.36 (s, 3H, CH3), 2.60-2.90 (In, 4H), 6.00 (s, 1H, H-3), 
7.10 (s, 1H, H-4), 8.12 (s, 1H, H-11); MS (re~z, %): 214 (M +, 100%). An~. Calcd. for CI4HisN2 (214.31): C, 
78.46; H, 8.47; N, 13.07%. Found: C, 78.63; H, 8.41; N, 13.12%. 
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